0001104659-23-077656.txt : 20230703 0001104659-23-077656.hdr.sgml : 20230703 20230703165652 ACCESSION NUMBER: 0001104659-23-077656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230703 DATE AS OF CHANGE: 20230703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirschbaum Mark CENTRAL INDEX KEY: 0001830211 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 231065772 MAIL ADDRESS: STREET 1: 66 WEST 38TH STREET, APT. 19D CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2320411-5_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-30 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001830211 Kirschbaum Mark C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 0 1 0 0 Chief Medical Officer 0 Stock Option (right to buy) 0.5891 2023-06-30 4 A 0 70200 0 A 2026-06-30 2033-06-30 Common Stock 70200 70200 D The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement. /s/ Mark Kirschbaum 2023-07-03